Viewing Study NCT00002669


Ignite Creation Date: 2025-12-24 @ 10:59 PM
Ignite Modification Date: 2025-12-25 @ 8:28 PM
Study NCT ID: NCT00002669
Status: COMPLETED
Last Update Posted: 2012-07-02
First Post: 2000-06-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module